Scout Investments’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-131,192
| Closed | -$2M | – | 221 |
|
|
2023
Q3 | $2M | Sell |
131,192
-3,815
| -3% | -$58K | 0.05% | 211 |
|
|
2023
Q2 | $2.53M | Sell |
135,007
-4,051
| -3% | -$76K | 0.05% | 210 |
|
|
2023
Q1 | $3.95M | Sell |
139,058
-1,584
| -1% | -$44.9K | 0.08% | 197 |
|
|
2022
Q4 | $4.11M | Sell |
140,642
-2,342
| -2% | -$68.5K | 0.08% | 196 |
|
|
2022
Q3 | $3.78M | Sell |
142,984
-4,050
| -3% | -$107K | 0.08% | 207 |
|
|
2022
Q2 | $6.53M | Sell |
147,034
-22,204
| -13% | -$987K | 0.13% | 175 |
|
|
2022
Q1 | $8.38M | Sell |
169,238
-228
| -0.1% | -$11.3K | 0.13% | 168 |
|
|
2021
Q4 | $8.63M | Sell |
169,466
-3,820
| -2% | -$195K | 0.13% | 204 |
|
|
2021
Q3 | $9.67M | Sell |
173,286
-3,627
| -2% | -$202K | 0.14% | 198 |
|
|
2021
Q2 | $7.57M | Buy |
176,913
+30,664
| +21% | +$1.31M | 0.11% | 229 |
|
|
2021
Q1 | $6.1M | Buy |
146,249
+14,280
| +11% | +$596K | 0.09% | 249 |
|
|
2020
Q4 | $6.15M | Buy |
131,969
+3,500
| +3% | +$163K | 0.11% | 247 |
|
|
2020
Q3 | $5.46M | Buy |
128,469
+44,114
| +52% | +$1.87M | 0.12% | 232 |
|
|
2020
Q2 | $4.05M | Sell |
84,355
-386
| -0.5% | -$18.5K | 0.1% | 236 |
|
|
2020
Q1 | $3.9M | Sell |
84,741
-5,109
| -6% | -$235K | 0.12% | 209 |
|
|
2019
Q4 | $5.4M | Sell |
89,850
-1,500
| -2% | -$90.1K | 0.1% | 211 |
|
|
2019
Q3 | $5.17M | Sell |
91,350
-7,460
| -8% | -$422K | 0.1% | 207 |
|
|
2019
Q2 | $5.5M | Buy |
98,810
+43,815
| +80% | +$2.44M | 0.11% | 201 |
|
|
2019
Q1 | $2.78M | Sell |
54,995
-1,316
| -2% | -$66.5K | 0.06% | 247 |
|
|
2018
Q4 | $2.27M | Buy |
56,311
+11,289
| +25% | +$455K | 0.06% | 240 |
|
|
2018
Q3 | $3.12M | Buy |
+45,022
| New | +$3.12M | 0.06% | 246 |
|